Ethical issues and risk/benefit assessment of iron chelation therapy: Advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.]

John B. Porter, Ali T. Taher, Maria D. Cappellini, Elliott P. Vichinsky

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)601-607
Number of pages7
JournalHemoglobin
Volume32
Issue number6
DOIs
Publication statusPublished - Nov 2008

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this